Bacterial distribution in lung parenchyma early after pulmonary infection with Pseudomonas aeruginosa

被引:35
|
作者
Schmiedl, Andreas [1 ]
Kerber-Momot, Tanja [1 ]
Munder, Antje [2 ]
Pabst, Reinhard [1 ]
Tschernig, Thomas [1 ]
机构
[1] Hannover Med Sch, Inst Funct & Appl Anat, D-30625 Hannover, Germany
[2] Hannover Med Sch, Clin Pediat Pneumol, D-30625 Hannover, Germany
关键词
Bacterial lung infection; Pseudomonas aeruginosa; Alveolar epithelial cells; Surfactant; Mouse model; SURFACTANT-PROTEIN-A; EPITHELIAL-CELLS; VIRULENCE; MACROPHAGES; PNEUMOCYTES; APOPTOSIS; INVASION; SEPSIS;
D O I
10.1007/s00441-010-1036-y
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Nosocomial infections often cause lethal pneumogenic sepsis. Information on early bacteria-host interaction in the lung is limited. In the present study, mice were sacrificed 60 min and 4 h after Pseudomonas aeruginosa (PA) infection to investigate lung morphology by using electron microscopy and light microscopy. After 1 h, bacteria were found in the alveoli partly in contact with surfactant. Alveolar macrophages were seen with up to 10 intracellular bacteria close to protrusions of alveolar epithelial type I cells and the gas/blood barrier. A rare but surprising finding was bacteria and even replicating bacteria in alveolar epithelial type II cells (AEII). No bacteria were seen in capillaries. Neither engulfment of bacteria by neutrophils nor structural damage of the pulmonary barrier was visible. After 4 h, many neutrophils were found within the capillaries, but also in the alveolar space. Thus, we hypothesize that, in early stages of infection, the uptake of PA even by single AEII can influence the course of the disease.
引用
收藏
页码:67 / 73
页数:7
相关论文
共 50 条
  • [21] The role of perilipin 2 in Pseudomonas aeruginosa pulmonary infection
    Wang, Hui
    Wen, Xiaoxing
    Yan, Mengnan
    Chang, Meijia
    Zhang, Ge
    Peng, Wenjun
    Wu, Yuanyuan
    Shen, Yao
    Zhou, Jian
    Li, Huayin
    RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2020, 281
  • [22] Role of flagella in pathogenesis of Pseudomonas aeruginosa pulmonary infection
    Feldman, M
    Bryan, R
    Rajan, S
    Scheffler, L
    Brunnert, S
    Tang, H
    Prince, A
    INFECTION AND IMMUNITY, 1998, 66 (01) : 43 - 51
  • [23] The Impact of Simvastatin on Pulmonary Effectors of Pseudomonas aeruginosa Infection
    Hennessy, Emma
    O'Callaghan, Julie
    Mooij, Marlies J.
    Legendre, Claire
    Camacho-Vanegas, Olga
    Camacho, Sandra C.
    Adams, Claire
    Martignetti, John A.
    O'Gara, Fergal
    PLOS ONE, 2014, 9 (07):
  • [24] Pharmacokinetics/Pharmacodynamics of Pulmonary Delivery of Colistin against Pseudomonas aeruginosa in a Mouse Lung Infection Model
    Lin, Yu-Wei
    Zhou, Qi Tony
    Cheah, Soon-Ee
    Zhao, Jinxin
    Chen, Ke
    Wang, Jiping
    Chan, Hak-Kim
    Li, Jian
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (03)
  • [25] Pseudomonas aeruginosa pyocyanin is critical for lung infection in mice
    Lau, GW
    Ran, HM
    Kong, FS
    Hassett, DJ
    Mavrodi, D
    INFECTION AND IMMUNITY, 2004, 72 (07) : 4275 - 4278
  • [26] Cystic fibrosis lung environment and Pseudomonas aeruginosa infection
    Anjali Y. Bhagirath
    Yanqi Li
    Deepti Somayajula
    Maryam Dadashi
    Sara Badr
    Kangmin Duan
    BMC Pulmonary Medicine, 16
  • [27] Cystic fibrosis lung environment and Pseudomonas aeruginosa infection
    Bhagirath, Anjali Y.
    Li, Yanqi
    Somayajula, Deepti
    Dadashi, Maryam
    Badr, Sara
    Duan, Kangmin
    BMC PULMONARY MEDICINE, 2016, 16
  • [28] Mechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection
    Curran, Colleen S.
    Bolig, Thomas
    Torabi-Parizi, Parizad
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197 (06) : 708 - 727
  • [29] Pseudomonas aeruginosa polymicrobial interactions during lung infection
    Bisht, Karishma
    Baishya, Jiwasmika
    Wakeman, Catherine A.
    CURRENT OPINION IN MICROBIOLOGY, 2020, 53 : 1 - 8
  • [30] Murine models of chronic Pseudomonas aeruginosa lung infection
    van Heeckeren, AM
    Schluchter, MD
    LABORATORY ANIMALS, 2002, 36 (03) : 291 - 312